Icon to close the modal
Modal Close Icon
Icon to close thank you modal
Thank you for contacting our sales team!
A sales representive will get in touch with you shortly.
Customer Care

BD PureHub™ Disinfecting Cap

Be sure. Be secure. Help reduce the risk of infection.

Contact Us

The BD PureHub™ Disinfecting Cap acts as a physical barrier between line accesses and is indicated as a disinfecting device for swabbable needle-free luer connectors prior to I.V. access.

BD Purehub™ Disinfecting Caps are part of the full BD® Vascular Access Management (VAM) portfolio designed to help reduce catheter related complications.

The use of disinfecting caps is supported by the 2014 Compendium of Prevention Recommendations from the Society for Healthcare Epidemiology of America (SHEA)1, The Joint Commission Central Line-Associated Bloodstream Infections (CLABSI) Toolkit: Valve Disinfection guidance2, the 2021 Infusion Nursing Standards of Practice3 (INS) and the Royal College of Nursing Infusion Therapy Standards4.

Features and Benefits


BD PureHub™ Disinfecting Caps disinfect with a sterilized 70% IPA solution, providing 99.99% (>4 log) reduction in bacteria within 1 minute of application.#†



The BD PureHub™ Disinfecting Cap maintains a physical barrier to contamination for up to 7 days, if not removed.*†

Compliance with INS guidelines

Disinfecting caps containing 70% isopropyl alcohol are supported by the INS 2021 guidelines3 for passive disinfection of needle-free connectors. 

Device compatibility

The BD PureHub™ Disinfecting Cap was designed for compatibility with needle-free connectors, including but not limited to, the BD SmartSite™ Needle-Free Connector, the BD MaxZero™ Needle-free Connector, and the BD Q-Syte™ Needle-Free Connector.

Related Videos

BD PureHub Disinfecting Cap for Needless Connectors



Please note, not all products, services or features of products and services may be available in your local area. Please check with your local BD representative.


#Demonstrated reduction on Staphylococcus aureus, Staphylococcus epidermidis, Pseudomonas aeruginosa, Escherichia coli, Candida glabrata, Candida albicans and Acinetobacter baumannii as tested in a laboratory.

bench Test results may not necessarily be indicative of clinical performance

*as demonstrated through in vitro studies

Warning: 70% Isopropyl Alcohol is not considered sporicidal and may not prevent Central Line-Associated Blood Stream Infection arising from bacterial spores (e.g., Bacillus spp., Clostridia)


  1. Yokoe, D., et al. A compendium of strategies to prevent healthcare-associated infections in acute care hospitals: 2014 updates. Infection Control and Hospital Epidemiology. Published on behalf of The Society for Healthcare Epidemiology of America (SHEA); 2014; 35:8, 967-977
  2. The Joint Commission. Preventing Central Line–Associated Bloodstream Infections: Useful Tools, An International Perspective. Nov 20, 2013. Accessed Apr 2023.
  3. Infusion Nurses Society. Infusion Nursing Standards of Practice. J Infus Nurs. 2021; 39(1S):S1-S159
  4. Royal College of Nursing's Standards for Infusion Therapy: an overview. Br J Nurs. 2018 Jan

BD-89187 (05/2023)